Connect with us

Health

NIPRD records gains in research, staff welfare, public health

info

Published

on

Image0 3 e1793392179144.jpeg

The National Institute for Pharmaceutical Research and Development (NIPRD) says it has recorded progress in research, staff welfare, infrastructure and public health interventions under the leadership of its Acting Director-General, Philip Builders.

The institute highlighted the reforms in a statement issued on Friday, citing improvements in staff welfare, restoration of basic infrastructure, efforts to strengthen research funding and intellectual property management, and its recent response to the Ebola outbreak.

“His administration is committed to strengthening the Institute’s capacity to fulfil its mandate and contribute to Nigeria’s pharmaceutical development, scientific innovation, and improved healthcare outcomes,” it noted.

One of the administration’s interventions has been the constitution of an Ebola Response Team, headed by Peters Oladisu, Director of the Department of Microbiology and Biotechnology.

NIPRD said it also supplied 17 cartons of hand sanitiser gel and 2,000 educational posters on Ebola symptoms and preventive measures to the Federal Ministry of Health and Social Welfare.

The institute said the intervention is part of its contribution to public awareness and prevention of emerging health threats.

PT WHATSAPP CHANNEL
Dangote Refinery AD

Staff welfare

NIPRD also cited improvements in staff welfare as part of the changes under Mr Builders.

The institute said it conducted its 2025 staff promotion exercise and addressed outstanding staff claims.

It also said salary arrears owed to security personnel, cleaners and gardeners had been settled.

Beyond staff-related measures, the institute said it restored electricity and water supply, which it described as critical to creating a more conducive environment for research and other activities.

Research and innovation

NIPRD said it was also strengthening its research and innovation ecosystem by restructuring its Intellectual Property and Technology Transfer Office and Grant Office.

It has established an Office for Strategic Partnerships and Commercialisation, headed by Adeola Jegede, a scientist with experience in policy, monitoring and evaluation.

The office is expected to facilitate partnerships, attract research opportunities and support the commercialisation of products developed from research carried out by the institute.

An example of the institute’s research efforts is the success of its scientist, Isaac Ajeh, who won a NASENI Innovation Grant for research into converting plantain peels into pharmaceutical products.

The project seeks to explore how agricultural waste can be transformed into useful pharmaceutical products, highlighting the potential intersection between local research, healthcare and sustainable innovation.

ALSO READ: UK increases Ebola response funding to £78.7m

NIPRD said it was also expanding its digital capacity through upgrades to its NCC Centre, computer-based testing facilities and other information and communication technology infrastructure.

According to the institute, the facilities will support computer-based examinations, digital research and technology-driven learning, while providing access to ICT facilities for schools in surrounding communities.

The administration has also supported researchers to participate in national and international training programmes, which the institute said would expose them to global best practices and strengthen scientific collaboration.

“Under Professor Builders’ leadership, NIPRD continues to pursue initiatives aimed at strengthening local pharmaceutical production, translating research into practical solutions, and improving Nigeria’s healthcare capacity,” it noted.


Discover more from Premium Times Nigeria

Subscribe to get the latest posts sent to your email.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

AMR Week: Artists, health experts use arts to raise awareness about drug resistance

info

Published

on

Arts exhibition at Microbe Madness 2.0 scaled.jpg

Artists and health experts are using art, storytelling and interactive activities to raise awareness about antimicrobial resistance (AMR).

AMR occurs when bacteria, viruses, fungi and parasites no longer respond to medicines used to treat infections, making diseases more difficult to manage.

The awareness event, Microbe Madness 2.0, organised by the Art for Health Initiative (AHI), was held in Lagos on Wednesday, the first day of the 2026 World AMR Awareness Week, observed from 18 to 24 November.

Olayinka Badmus and Media EIS Frontliners
Olayinka Badmus and Media EIS Frontliners

The event themed: One Action for our Future, featured exhibitions by artists exploring AMR and other health-related themes, including a mental health exhibition showcasing works produced by artists who participated in an earlier workshop organised by AHI.

It also featured spoken-word performances by Ruth Mahogany, music by Nanya ljeh and Paragon, and interactive games designed to help participants understand AMR and how everyday actions can help prevent it.

Philip Osun
Philip Osun

Antibiotics misuse

Delivering the keynote address at the event, Philip Osun, a clinical microbiologist at the Lagos University Teaching Hospital (LUTH), warned against the indiscriminate use of antibiotics.

PT WHATSAPP CHANNEL
Dangote Refinery AD

Mr Osun said antibiotics are designed to treat bacterial infections and are ineffective against viral illnesses such as most common colds.

“Don’t rush to the chemist and say I need antibiotics,” Mr Osun said, urging people to seek medical advice rather than self-medicate.

He also cautioned against taking antibiotics prescribed for others, sharing medicines or starting, stopping or changing treatment without professional advice.

According to him, antimicrobial resistance occurs when germs develop mechanisms to overcome medicines designed to treat them, making infections difficult to manage.

Mr Osun said the consequences could include prolonged illness, expensive treatment and increased pressure on families and healthcare facilities.

The World Health Organisation (WHO), in a statement to mark the start of World AMR Awareness Week, said bacterial AMR was associated with an estimated 4.7 million deaths globally in 2021, with sub-Saharan Africa recording the highest rates of AMR-associated mortality.

The WHO said tackling resistance requires action across human, animal, plant and environmental health, noting that inappropriate use of antimicrobials, poor infection prevention, inadequate water and sanitation, and unsafe waste disposal contribute to its spread.

Chidera Aneke
Chidera Aneke

Preventing infections

The microbiologist encouraged Nigerians to prevent infections through regular handwashing, vaccination, safe food and water practices, proper wound care and good hygiene.

He said preventing infections reduces the need for antimicrobials and helps limit the development and spread of resistance.

Mr Osun also explained the One Health approach, noting that human, animal and environmental health are interconnected.

He said antimicrobial resistance is not only a human health problem but also involves animals and the environment, requiring coordinated efforts to prevent infections and reduce inappropriate antimicrobial use.

Using art to communicate health messages

Speaking about the initiative, Chidera Aneke, founder of AHI and a Media EIS Frontliner, said AMR remains poorly understood despite its growing impact.

READ ALSO: World Antibiotic Awareness Week: New health challenge emerges with antibiotics misuse

Ms Aneke said the organisation uses art and creative activities to communicate health information in ways people can relate to and remember.

She said the initiative plans to make Microbe Madness an annual event and involve more creatives in public health awareness.

“With more funding, we can make this a yearly event,” she said, adding that the initiative wants people to learn about health issues through activities that are enjoyable and interactive, rather than only workshops and seminars.

The event also had in attendance Olayinka Badmus, Resident Adviser for the Media EIS Fellowship and Technical Director at Afrihealth for Social Development and Impact (ASDI).

It was organised with DRASA Health Trust as a technical partner and support from the Yemisi Shyllon Museum of Art and BNL Healthcare Limited.


Discover more from Premium Times Nigeria

Subscribe to get the latest posts sent to your email.

Continue Reading

Health

AMR: Pharmacist urges Nigeria to implement policies to curb drug resistance

info

Published

on

20261119 113031 scaled.jpg

Nigeria needs to translate its antimicrobial resistance (AMR) policies into action to curb the growing threat of drug-resistant infections, a pharmacist has said.

Folashade Lawal, managing director and chief executive officer of Victory Drugs, said the country had developed policies and guidelines to address AMR but faced challenges implementing them across healthcare facilities and communities.

“The challenge now lies not in planning but in implementation,” Ms Lawal said on Thursday while delivering the ninth Ladipo Mobolaji Abisogun-Afodu Annual Lecture in Pharmacy at the College of Medicine, University of Lagos.

The lecture, titled Addressing Antimicrobial Stewardship in Nigeria: Current Perspectives and Future Imperatives, was held during the 2026 World Antimicrobial Resistance Awareness Week, observed from 18 to 24 November.

Folashade Lawal, Pharmacist and Founder of Victory Drugs

Policies, implementation gaps

Nigeria’s first National Action Plan on Antimicrobial Resistance covered 2017 to 2022. The plan sought to reduce, prevent and slow the emergence of resistant organisms through awareness, surveillance, infection prevention and control, responsible antimicrobial use, and research.

PT WHATSAPP CHANNEL

An assessment of its implementation found that only 44 per cent of the plan’s activities had been completed, highlighting gaps in coordination, funding and implementation across sectors.

Dangote Refinery AD

Nigeria subsequently launched its second One Health National Action Plan on AMR, covering 2024 to 2028, with six strategic objectives, including stronger governance, surveillance, public awareness, infection prevention and control, responsible antimicrobial use, and research and capacity development.

Ms Lawal said antimicrobial stewardship activities are yet to become routine in many healthcare institutions, despite the country’s policy commitments.

She called for stronger enforcement of regulations governing antimicrobial sales, sustainable funding for stewardship programmes at federal, state and institutional levels, improved access to diagnostic services and laboratory infrastructure, and the establishment of stewardship programmes across healthcare facilities.

She also urged the government to strengthen antimicrobial consumption monitoring, invest in workforce development and research, and expand public awareness of responsible antimicrobial use.

In his welcome remarks, the Dean of the Faculty of Pharmacy, University of Lagos, Sunday Adesegun, said antimicrobial resistance threatened the effective treatment of infectious diseases and could reverse gains made in modern medicine.

He said Nigeria continued to grapple with self-medication, indiscriminate access to antibiotics, inadequate infection prevention and control, and gaps in antimicrobial resistance surveillance.

“Antimicrobial stewardship is not merely a professional responsibility; it is a collective obligation to safeguard public health,” Mr Adesegun said, urging stakeholders to move beyond awareness to concrete action.

Folashade Lawal, Pharmacist and Founder of Victory Drugs

Growing threat

Ms Lawal described antimicrobial resistance as a “silent pandemic” that steadily undermines the effectiveness of medicines used to treat infections.

She said bacterial antimicrobial resistance was associated with approximately 4.7 million deaths globally in 2021, including 1.14 million deaths directly attributable to resistant infections.

In Nigeria, she cited estimates that antimicrobial resistance was directly responsible for 50,500 deaths and associated with about 227,000 deaths in 2021.

She warned that resistance threatens not only the treatment of common infections but also modern medical procedures, including surgery, cancer treatment, organ transplantation, neonatal care and intensive care, which depend on effective antimicrobials.

Ms Lawal identified self-medication, inappropriate prescribing and dispensing, unrestricted access to antibiotics, weak regulatory enforcement, inadequate infection prevention and control, and limited diagnostic capacity as major drivers of antimicrobial resistance.

She said inadequate laboratory services often leave healthcare professionals relying on empirical treatment without diagnostic confirmation.

Pharmacists’ role

Ms Lawal urged community pharmacists to refuse inappropriate antibiotic supply without valid prescriptions, source medicines from regulated suppliers, counsel patients on proper use and refer patients for medical care when necessary.

She said hospital pharmacists should support stewardship through prescription reviews, monitoring antimicrobial consumption and collaborating with other healthcare professionals to optimise treatment.

She also called for antimicrobial stewardship to be integrated into pharmacy education and for stronger collaboration among healthcare professionals.

The chairman of the occasion, Olumide Akintayo, a former president of the Pharmaceutical Society of Nigeria, said healthcare professionals, government and other stakeholders had contributed to inappropriate antimicrobial use.

He called for urgent action, including improved regulation, public awareness and responsible professional practice.

He also noted that Nigeria would host the fifth Global High-Level Ministerial Conference on Antimicrobial Resistance in December.

READ ALSO: Plateau pharmacists campaign against child marriage, urge girl-child education

Research grant

At the event, Olusegun Ajala of the Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Lagos, won the 2026 Ladipo Mobolaji Abisogun-Afodu Research Grant Award in Pharmacy and received N2.7 million.

His proposal, titled Development of a Psidium guajava-Based Antibiotic Adjuvant for Restoring the Susceptibility of Multidrug-Resistant Bacteria to Conventional Antibiotics, was selected as the winning research proposal.

Deborah Ogundemuren and colleagues from the Department of Pharmaceutics and Pharmaceutical Technology came second with a proposal to develop a bioactive, sprayable hydrogel for postpartum perineal wound care as an antibiotic-sparing strategy.

Osideko Oluwaseun and colleagues from the Department of Pharmaceutical Chemistry came third with a proposal on the chemical standardisation and antibacterial characterisation of fermented maize mash supernatant, known as omidun, produced using different fermentation strategies.


Discover more from Premium Times Nigeria

Subscribe to get the latest posts sent to your email.

Continue Reading

Trending